James Huang, Director at CASI Pharmaceuticals, Inc. (CASI), bought 62,171 shares at $3.75 ($233K) on 2022-08-31, disclosed to the SEC on 2022-09-02.
Open-market purchase of $233k CASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 24,975 | $94K | 40.2% |
| 2 | $3.75 | 24,975 | $94K | 40.2% |
| 3 | $3.72 | 11,821 | $44K | 18.9% |
| 4 | $3.74 | 400 | $1K | 0.6% |
| Total | $3.74 avg | 62,171 | $233K | 100% |
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |